Form 4 for BSX Boston Scientific
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-15 · accession 0001225208-23-002157 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-16 | 2023-02-15 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +1,846 | 62.5K | +3% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $47.29 | -1,069 | 61.4K | -2% | -$50.6K |
| D | 2023-02-16 | 2023-02-15 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | -1,846 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-15 | M | A | 1,846 | $0.00 | 62,483.99 | D | — | — | (F1) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| 2 | Common | Common Stock | 2023-02-15 | F | D | 1,069 | $47.29 | 61,414.99 | D | — | — | |
| 3 | Derivative | Deferred Stock Units | 2023-02-15 | M | D | 1,846 | $0.00 | 0 | D | — · — to 2023-02-15 | 1,846 Common Stock | (F1) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F2) Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. |